Jay H Shubrook Selected Research

Jay H Shubrook Research Topics

Disease

23	Type 2 Diabetes Mellitus (MODY) 01/2024 - 02/2011
7	Diabetes Mellitus 01/2023 - 08/2010
7	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 07/2010
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2018 - 07/2008
4	Weight Loss (Weight Reduction) 10/2021 - 08/2017
4	Hyperglycemia 01/2021 - 01/2008
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 08/2010
3	Body Weight (Weight, Body) 05/2022 - 07/2017
3	Hypertension (High Blood Pressure) 01/2018 - 01/2011
3	Weight Gain 08/2017 - 07/2010
2	Pain (Aches) 04/2024 - 12/2019
2	Chronic Renal Insufficiency 01/2023 - 01/2022
1	Heart Failure 01/2023
1	Body Weight Changes 01/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Neoplasms (Cancer) 07/2020
1	Chronic Pain 12/2019
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Prediabetic State (Prediabetes) 01/2017
1	Gastroparesis 07/2015
1	Vascular Diseases (Vascular Disease) 09/2014
1	Polyps 09/2013
1	Adenoma (Adenomas) 09/2013
1	Diabetes Complications 07/2011
1	Albuminuria 01/2011
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2010
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 08/2010
1	Human Influenza (Influenza) 06/2007

Drug/Important Bio-Agent (IBA)

15	Insulin (Novolin)FDA Link 01/2024 - 01/2008
12	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2008
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 06/2016 - 07/2010
3	Glucagon-Like Peptide-1 ReceptorIBA 01/2024 - 08/2017
3	LipidsIBA 05/2022 - 06/2007
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 04/2015
3	LDL CholesterolIBA 01/2021 - 01/2011
3	Blood Glucose (Blood Sugar)IBA 08/2018 - 01/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2011
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2011
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 06/2007
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022
1	A 7 (A-7)IBA 10/2021
1	4-nitro-3-dimethylaminopropiophenoneIBA 10/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	semaglutideIBA 11/2020
1	Naloxone (Narcan)FDA LinkGeneric 12/2019
1	Opioid Analgesics (Opioids)IBA 12/2019
1	Sweetening Agents (Sweeteners)IBA 07/2019
1	IDegLiraIBA 08/2017
1	Triglycerides (Triacylglycerol)IBA 07/2017
1	HDL LipoproteinsIBA 07/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2017
1	Indicators and Reagents (Reagents)IBA 01/2016
1	SecretagoguesIBA 04/2015
1	empagliflozinIBA 01/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 09/2014
1	IncretinsIBA 05/2014
1	Metformin (Glucophage)FDA LinkGeneric 09/2013
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2011
1	oxidized low density lipoproteinIBA 01/2011

Therapy/Procedure

12	Therapeutics 01/2024 - 07/2008
5	Glycemic Control 01/2023 - 07/2010
3	Osteopathic Manipulation 04/2024 - 11/2013
2	Injections 08/2018 - 01/2012
2	Secondary Prevention 05/2014 - 08/2010
1	Polypharmacy 01/2015